Yamaguchi, Akinori Harada, Makoto Yamada, Yosuke Hashimoto, Koji Kamijo, Yuji Additional file 1: Table S1. of Identification of chronic kidney disease patient characteristics influencing the renoprotective effects of febuxostat therapy: a retrospective follow-up study Adverse events. There were 15 cases wherein febuxostat treatment was discontinued owing to various adverse events. In most patients, the adverse events developed during the initial dosing of febuxostat at 10 mg/day. (DOCX 18 kb) Chronic kidney disease;Febuxostat;Hyperuremia;Uric acid;Vascular risk factors 2017-05-18
    https://springernature.figshare.com/articles/journal_contribution/Additional_file_1_Table_S1_of_Identification_of_chronic_kidney_disease_patient_characteristics_influencing_the_renoprotective_effects_of_febuxostat_therapy_a_retrospective_follow-up_study/5023652
10.6084/m9.figshare.c.3783296_D1.v1